UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16

~~PURSUANT TO RULE 13a-16~~ OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

~~UNDER~~For ~~THE~~the ~~SECURITIES~~month ~~EXCHANGE~~of ~~ACT~~March ~~OF 1934~~2025

~~For~~Commission ~~the~~File ~~month~~Number ~~of March, 2025~~001-42299

Commission File Number: 001-42299

SAMFINE CREATION HOLDINGS GROUP LIMITED

(Registrant’s Name)

Flat B, 8/F, Block 4
Kwun Tong Industrial Centre
436-446 Kwun Tong Road
Kwun Tong, Kowloon

Hong Kong

(Address of ~~Principal~~principal ~~Executive~~executive ~~Offices~~office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

~~Nasdaq~~Extraordinary ~~Minimum~~Shareholder ~~Bid Price Deficiency Letter~~Meeting

~~On March~~In ~~25,~~connection ~~2025,~~with the extraordinary meeting of shareholders of Samfine Creation Holdings Group Limited (the “Company”) ~~received~~, ~~a letter from~~ the ~~Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the~~ Company ~~that~~hereby ~~based~~furnishes on the ~~closing bid price of the Company for the period from February 6, 2025 to March 20, 2025, the~~following ~~Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of $1 per share.~~documents:

Nasdaq has provided the Company with an 180 calendar days compliance period, or until September 22, 2025, in which to regain compliance with Nasdaq continued listing requirement. In the event that the Company does not regain compliance in the compliance period, the Company may be eligible for an additional 180 calendar days, should the Company meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and is able to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. However, if it appears that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice that the Company’s securities will be subject to delisting.Exhibits

The Company is currently evaluating options to regain compliance and intends to timely regain compliance with Nasdaq’s continued listing requirement. Although the Company will use all reasonable efforts to achieve compliance with Rule 5550(a)(2), there can be no assurance that the Company will be able to regain compliance with that rule or will otherwise be in compliance with other Nasdaq continued listing requirement.

Exhibit No.		Description
99.1		Proxy Statement and Notice of Extraordinary Meeting of Shareholders, dated March 31, 2025
99.2		Form of Proxy Card of Extraordinary Meeting of Shareholders
99.3		Form of second amended and restated memorandum and articles of association

On March 26, 2025, the Company issued a press release discussing the receipt of the deficiency letter, which is filed as exhibit 99.1 to this Form 6-K.

Exhibit Index

Exhibit Number		Description
99.1		Press Release dated March 26, 2025

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Samfine Creation Holdings Group Limited
Date: March 26, 2025	By:	/s/ Wing Wah Cheng, Wayne
	Name:	Wing Wah Cheng, Wayne
	Title:	Chairman of the Board, Executive Director and Chief Executive Officer

	SAMFINE CREATION HOLDINGS GROUP LIMITED

	By:	/s/ Wing Wah Cheng, Wayne
	Name:	Wing Wah Cheng, Wayne
	Title:	Chairman of the Board, Executive Director and Chief Executive Officer

Date: March 31, 2025

Filing Compare · SAMFINE CREATION HOLDINGS GROUP Ltd